Expression levels of the tumor cell–autonomous gene IFNGR1 and downstream signaling axis and effector genes, including JAK1, JAK2, and IRF1, were all significantly lower in PRC2-loss tumors than in PRC2-wt tumors (P < 0.05; Figure 2B). The gene discussed is IRF1; the disease is neoplasm.